Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FAAH | O00519 | 5/20 | 0.56 |
| ▸ | CA2 | P00918 | 6/20 | 0.50 |
| ▸ | TSHR | P16473 | 2/20 | 0.44 |
| ▸ | THRB | P10828 | 1/20 | 0.44 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | CES1 | P23141 | 2/20 | 0.41 |
| ▸ | CES2 | O00748 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7252868 | 1.00 | FAAH (0.56) | FAAHCA2TSHRTHRBEPHX2 | |
| SCHEMBL1114761 | 1.00 | FAAH (0.56) | FAAHCA2TSHRTHRBEPHX2 | |
| SCHEMBL744300 | 1.00 | FAAH (0.56) | FAAHCA2TSHRTHRBEPHX2 | |
| SCHEMBL11719482 | 1.00 | FAAH (0.56) | FAAHCA2TSHRTHRBEPHX2 | |
| SCHEMBL11381720 | 1.00 | FAAH (0.56) | FAAHCA2TSHRTHRBEPHX2 | |
| SCHEMBL94158 | 1.00 | FAAH (0.56) | FAAHCA2TSHRTHRBEPHX2 | |
| SCHEMBL11411801 | 1.00 | FAAH (0.56) | FAAHCA2TSHRTHRBEPHX2 | |
| SCHEMBL743460 | 1.00 | FAAH (0.56) | FAAHCA2TSHRTHRBEPHX2 | |
| SCHEMBL9834817 | 1.00 | FAAH (0.56) | FAAHCA2TSHRTHRBEPHX2 | |
| SCHEMBL31126199 | 1.00 | FAAH (0.56) | FAAHCA2TSHRTHRBEPHX2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 126 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2011045807-A2 | A NOVEL PROCESS TO MANUFACTURE (2R,3S)-2-(2,4-DIFLUOROPHENYL)-3-(5-FLUOROPYRIMIDIN-4-YL)-1-(1H-1,2,4-TRIAZOL-1-YL)BUTAN-2-OL | NEULAND LABORATORIES LTD. (IN) | 2011-04-21 | — | — | WO | claimed |
| WO-2010115869-A1 | PROPOFOL PHOSPHONYL DERIVATIVES, SYNTHESIS, AND USE IN LONG ACTING FORMULATIONS | SEPS PHARMA N.V. (BE) | 2010-10-14 | — | — | WO | claimed |
| WO-2025075722-A1 | PRODUCTION METHOD FOR SOLID CATALYST COMPONENT FOR POLYMERIZING OLEFINS, AND CATALYST FOR POLYMERIZAING OLEFINS | FORMOSA PLASTICS CORPORATION, U.S.A. (US) | 2025-04-10 | — | — | WO | disclosed |
| US-20250115687-A1 | PRODUCTION METHOD FOR SOLID CATALYST COMPONENT FOR POLYMERIZING OLEFINS, AND CATALYST FOR POLYMERIZAING OLEFINS | FORMOSA PLASTICS CORP USA (US) | 2025-04-10 | — | — | US | disclosed |
| US-20240307863-A1 | STYRENIC FLUOROPOLYMERS AND METHODS FOR MAKING AND USING SAME | University of Louisiana Lafayette (US) | 2024-09-19 | — | — | US | disclosed |
| US-11702394-B2 | Inhibitors of phospholipid synthesis and methods of use | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) | 2023-07-18 | — | — | US | disclosed |
| CN-106661084-B | Macrocyclic broad spectrum antibiotics | 阿奇克斯制药公司 | 2021-08-31 | — | — | CN | disclosed |
| EP-3145944-B1 | MACROCYCLIC BROAD SPECTRUM ANTIBIOTICS | RQX PHARMACEUTICALS INC (US) | 2021-05-05 | — | — | EP | disclosed |
| US-10392422-B2 | Macrocyclic broad spectrum antibiotics | RQX PHARMACEUTICALS, INC. (US) | 2019-08-27 | — | — | US | disclosed |
| US-10351595-B2 | — | — | 2019-07-16 | — | — | US | disclosed |
| CN-109337657-A | The improved silica material and its preparation method and application of bits agent is taken with fluorine carbon activity agent class super-amphiphobic suitable for water-base drilling fluid | 中国石油大学(北京) | 2019-02-15 | — | — | CN | disclosed |
| WO-1994028004-A1 | DESOXYAZAPHOSPHOLIPID DERIVATIVES HAVING INHIBITING ACTIVITY ON PHOSPHOLIPASE A2 | LABORATORIOS MENARINI S.A. (ES) | 1994-12-08 | — | — | WO | disclosed |
| WO-1992016495-A1 | AMIDE ANTIOXIDANTS | ETHYL CORPORATION (US) | 1992-10-01 | — | — | WO | disclosed |
| US-5103054-A | Polymer antioxidant | ETHYL CORPORATION (US) | 1992-04-07 | — | — | US | disclosed |
| US-5102934-A | For use with ethylenically unsaturated hydrocarbons | ETHYL CORPORATION (US) | 1992-04-07 | — | — | US | disclosed |
| US-4835312-A | Production process of N-substituted amide compounds | MITSUI CHEMICALS, INCORPORATED (JP) | 1989-05-30 | — | — | US | disclosed |
| US-RE29577-E | Anthraquinone dyestuffs | BAYER AKTIENGESELLSCHAFT (DT) | 1978-03-14 | — | — | US | disclosed |
| US-4056622-A | MICROBIOCIDES, FUNGICIDES, BACTERICIDES | SUMITOMO CHEMICAL COMPANY, LIMITED (JA) | 1977-11-01 | — | — | US | disclosed |
| US-3963763-A | Anthraquinone dyestuffs | BAYER AKTIENGESELLSCHAFT (DT) | 1976-06-15 | — | — | US | disclosed |
| US-3932419-A | QUINOLINE DYES | BAYER AKTIENGESELLSCHAFT (DT) | 1976-01-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11702394-B2 | Inhibitors of phospholipid synthesis and methods of use | LCAT, AGPAT2, GNPAT | FAAH 586/4885CA2 2799/4885TSHR 2550/4885 |
| US-10351595-B2 | — | MRPL21, PRSS1, PEPD | FAAH 2818/4885CA2 3717/4885TSHR 4401/4885 |
| US-10392422-B2 | Macrocyclic broad spectrum antibiotics | MRPL21, PEPD, CTSC | FAAH 3193/4885CA2 4501/4885TSHR 4174/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.